oric-944
oric-944: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Oric Pharmaceuticals, Inc. (ORIC) | Phase 1 |
Clinical Trials (1)
An Open-Label, Phase 1/1b Study of ORIC-944 as a Single Agent or in Combination With an Androgen Receptor Pathway Inhibitor in Patients With Metastatic Prostate Cancer
Frequently asked questions
Who is developing oric-944?
oric-944 is being developed by Oric Pharmaceuticals, Inc..
How many clinical trials involve oric-944?
BioSniper tracks 1 clinical trial involving oric-944.
Get deeper analysis on oric-944
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis